Table: Aska Pharmaceutical Holdings -2021/22 group forecast

ASKA Pharmaceutical Holdings

27/09/2021 07:00

Sept 27 (Reuters) -
              Aska Pharmaceutical Holdings Co., Ltd.     
              CONSOLIDATED EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2022      Mar 31, 2022   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales            54.50             52.00      
  Operating         3.50              1.50      
  Recurring         3.60              1.50      
  Net            loss 2.60          800 mln     
  EPS         loss 91.62 yen       29.33 yen    
 
  NOTE - Aska Pharmaceutical Holdings Co., Ltd..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T